{"id":"https://openalex.org/W7217120482","doi":null,"title":"Lipophilic Emtricitabine prodrugs for targeting HIV reservoirs in mesenteric lymph nodes","display_name":"Lipophilic Emtricitabine prodrugs for targeting HIV reservoirs in mesenteric lymph nodes","alternate_titles":[],"publication_year":2026,"publication_date":"2026-07-29","ids":{"openalex":"https://openalex.org/W7217120482"},"language":"en","primary_location":{"id":"pmh:oai:repository.nottingham.ac.uk:123456789/78225","doi":null,"is_oa":true,"landing_page_url":"https://repository.nottingham.ac.uk/handle/123456789/78225","pdf_url":null,"source":{"id":"https://openalex.org/S4306402014","display_name":"Nottingham ePrints (University of Nottingham)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I142263535","host_organization_name":"University of Nottingham","host_organization_lineage":["https://openalex.org/I142263535"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nd","license_id":"https://openalex.org/licenses/cc-by-nd","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"ethesis"},"parent_works":[],"lineage":["https://openalex.org/W7217120482"],"child_works_count":0,"type":"dissertation","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://repository.nottingham.ac.uk/handle/123456789/78225","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5114660296","display_name":"Graziamarina Sinatra","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Graziamarina Sinatra","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":["https://openalex.org/A5114660296"],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10526","display_name":"HIV/AIDS drug development and treatment","score":0.5824999809265137,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10526","display_name":"HIV/AIDS drug development and treatment","score":0.5824999809265137,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10256","display_name":"Drug Solubulity and Delivery Systems","score":0.19460000097751617,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10920","display_name":"Advanced Drug Delivery Systems","score":0.05249999836087227,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/emtricitabine","display_name":"emtricitabine","score":0.972000002861023},{"id":"https://openalex.org/keywords/lipophilic-prodrugs","display_name":"lipophilic prodrugs","score":0.875},{"id":"https://openalex.org/keywords/hiv-reservoir","display_name":"HIV reservoir","score":0.8349999785423279},{"id":"https://openalex.org/keywords/mesenteric-lymph-nodes","display_name":"mesenteric lymph nodes","score":0.9959999918937683},{"id":"https://openalex.org/keywords/gut-associated-lymphoid-tissue","display_name":"gut-associated lymphoid tissue","score":0.9459999799728394},{"id":"https://openalex.org/keywords/lipid-based-drug-delivery-systems","display_name":"lipid-based drug delivery","score":0.6940000057220459},{"id":"https://openalex.org/keywords/nucleoside-reverse-transcriptase-inhibitors","display_name":"nucleoside reverse transcriptase inhibitors","score":0.7990000247955322},{"id":"https://openalex.org/keywords/hplc-uv-assay","display_name":"HPLC-UV assay","score":0.531000018119812}],"concepts":[{"id":"https://openalex.org/C2779778239","wikidata":"https://www.wikidata.org/wiki/Q422604","display_name":"Emtricitabine","level":5,"score":0.8098000288009644},{"id":"https://openalex.org/C108215921","wikidata":"https://www.wikidata.org/wiki/Q603741","display_name":"Prodrug","level":2,"score":0.7782999873161316},{"id":"https://openalex.org/C2779720271","wikidata":"https://www.wikidata.org/wiki/Q179422","display_name":"Lymph","level":2,"score":0.7268999814987183},{"id":"https://openalex.org/C181152851","wikidata":"https://www.wikidata.org/wiki/Q712604","display_name":"Lymphatic system","level":2,"score":0.6279000043869019},{"id":"https://openalex.org/C2779237934","wikidata":"https://www.wikidata.org/wiki/Q7643652","display_name":"Mesenteric lymph nodes","level":3,"score":0.5708000063896179},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5658000111579895},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5397999882698059},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.515500009059906},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.5108000040054321},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.40619999170303345},{"id":"https://openalex.org/C142462285","wikidata":"https://www.wikidata.org/wiki/Q2528140","display_name":"Viral load","level":3,"score":0.39259999990463257},{"id":"https://openalex.org/C3013748606","wikidata":"https://www.wikidata.org/wiki/Q15787","display_name":"Human immunodeficiency virus (HIV)","level":2,"score":0.37299999594688416},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.3537999987602234},{"id":"https://openalex.org/C2777869810","wikidata":"https://www.wikidata.org/wiki/Q422631","display_name":"Lamivudine","level":4,"score":0.3517000079154968},{"id":"https://openalex.org/C2777351918","wikidata":"https://www.wikidata.org/wiki/Q421559","display_name":"Reverse-transcriptase inhibitor","level":5,"score":0.34389999508857727},{"id":"https://openalex.org/C11772777","wikidata":"https://www.wikidata.org/wiki/Q423126","display_name":"Chylomicron","level":5,"score":0.3402000069618225},{"id":"https://openalex.org/C159047783","wikidata":"https://www.wikidata.org/wiki/Q7215","display_name":"Virology","level":1,"score":0.32499998807907104},{"id":"https://openalex.org/C2993143319","wikidata":"https://www.wikidata.org/wiki/Q583050","display_name":"Antiretroviral therapy","level":4,"score":0.304500013589859},{"id":"https://openalex.org/C2779820397","wikidata":"https://www.wikidata.org/wiki/Q1392806","display_name":"Drug delivery","level":2,"score":0.2946999967098236},{"id":"https://openalex.org/C140704245","wikidata":"https://www.wikidata.org/wiki/Q3933202","display_name":"Viral replication","level":3,"score":0.28439998626708984},{"id":"https://openalex.org/C2778549279","wikidata":"https://www.wikidata.org/wiki/Q962200","display_name":"Cervical lymph nodes","level":4,"score":0.2815999984741211},{"id":"https://openalex.org/C2777333352","wikidata":"https://www.wikidata.org/wiki/Q2689559","display_name":"Nucleoside analogue","level":3,"score":0.2689000070095062},{"id":"https://openalex.org/C156719811","wikidata":"https://www.wikidata.org/wiki/Q28774","display_name":"Reverse transcriptase","level":4,"score":0.2578999996185303}],"mesh":[],"locations_count":1,"locations":[{"id":"pmh:oai:repository.nottingham.ac.uk:123456789/78225","doi":null,"is_oa":true,"landing_page_url":"https://repository.nottingham.ac.uk/handle/123456789/78225","pdf_url":null,"source":{"id":"https://openalex.org/S4306402014","display_name":"Nottingham ePrints (University of Nottingham)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I142263535","host_organization_name":"University of Nottingham","host_organization_lineage":["https://openalex.org/I142263535"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nd","license_id":"https://openalex.org/licenses/cc-by-nd","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"ethesis"}],"best_oa_location":{"id":"pmh:oai:repository.nottingham.ac.uk:123456789/78225","doi":null,"is_oa":true,"landing_page_url":"https://repository.nottingham.ac.uk/handle/123456789/78225","pdf_url":null,"source":{"id":"https://openalex.org/S4306402014","display_name":"Nottingham ePrints (University of Nottingham)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I142263535","host_organization_name":"University of Nottingham","host_organization_lineage":["https://openalex.org/I142263535"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nd","license_id":"https://openalex.org/licenses/cc-by-nd","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"ethesis"},"sustainable_development_goals":[{"score":0.9940000176429749,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W7039400786","https://openalex.org/W1968661040","https://openalex.org/W3155914574","https://openalex.org/W4386171534","https://openalex.org/W3093894312","https://openalex.org/W7015587124","https://openalex.org/W6996842247","https://openalex.org/W4388378635","https://openalex.org/W4416335036","https://openalex.org/W7217355235"],"abstract_inverted_index":{"Despite":[0],"the":[1,5,63,120,123,138,142,165,201,248,251,267,272,327,388,427,430,467,476,479,519,527,562,568,612,634,644,668,716,757,766,780,785,790,818,890,908,980,990],"great":[2],"advances":[3],"in":[4,30,41,74,99,106,189,287,315,323,330,344,347,356,389,426,475,485,490,549,563,584,592,609,647,650,653,675,691,699,723,728,752,821,824,925,959,963,969,970,984,1003,1008],"treatment":[6,38,133],"of":[7,37,46,62,88,94,122,148,179,206,247,250,269,295,297,451,529,542,545,573,765,768,850,910,982,992],"human":[8],"immunodeficiency":[9],"virus-1":[10],"(HIV-1),":[11],"there":[12],"is":[13,57,79],"still":[14],"no":[15,950],"definitive":[16],"standardised":[17],"cure":[18],"for":[19,131,160,284,309,567,571,581,751,831,859,873,999],"it.":[20],"While":[21],"current":[22],"antiretroviral":[23],"therapy":[24],"(ART)":[25],"effectively":[26],"suppresses":[27],"viral":[28,42,50,113],"load":[29],"plasma":[31,289,618,724,822],"restoring":[32],"CD4":[33],"cell":[34],"count,":[35],"cessation":[36],"can":[39,232],"result":[40,205,246],"rebound.":[43],"The":[44,158,177,460,594,620,680,702,813,826],"persistence":[45],"anatomical":[47],"and":[48,111,228,300,322,335,346,353,365,386,410,415,470,494,497,510,557,587,652,677,710,725,770,798,802,845,866,882,929,988,1005],"cellular":[49],"reservoirs":[51,140,274],"established":[52],"during":[53],"primary":[54],"infection":[55],"stage":[56],"considered":[58],"to":[59,84,118,137,198,260,265,271,338,376,381,454,561,590,720,748,807,841,897],"be":[60],"one":[61],"main":[64],"reasons":[65],"behind":[66],"this.":[67],"Among":[68,755],"these,":[69],"gut-associated":[70],"lymphoid":[71],"tissue":[72],"(GALT),":[73],"particular":[75,100],"mesenteric":[76,102,143,276,486,933],"lymph":[77,103,144,277,487,506,927,934,986,1004],"nodes,":[78,104],"a":[80,149,155,204,245,280,293,303,318,404,416,433,455,599,616,627,711,888,996,1000],"key":[81],"reservoir":[82],"due":[83],"its":[85,207,336,383],"large":[86],"population":[87],"CD4+":[89],"T":[90],"cells.":[91],"Poor":[92],"penetration":[93],"antiretrovirals":[95],"into":[96,101,171,193,401,979],"these":[97,947],"tissues,":[98],"results":[105,621],"subtherapeutic":[107],"local":[108],"drug":[109,169,253,409,421,431,480,782],"levels":[110],"prevents":[112],"eradication.":[114],"This":[115,242,256,521,743],"work":[116],"aimed":[117,259],"improve":[119,266],"delivery":[121,268],"first":[124],"line":[125],"nucleoside":[126],"reverse":[127],"transcriptase":[128],"inhibitor":[129],"(NRTI)":[130],"HIV":[132,139,273],"emtricitabine":[134],"((\u2212)-2'-deoxy-5-fluoro-3'-thiacytidine,":[135],"FTC),":[136],"within":[141,275],"nodes":[145,488,928,987],"by":[146,537,614,922],"means":[147],"lipophilic":[150,218,252,543],"prodrug":[151,682,787,791,851,900,956],"approach":[152],"combined":[153],"with":[154,224,240,254,340,408,420,441,547,598,605,630,640,664,730,817,834,995],"lipid-based":[156,405,477,797,857],"formulation.":[157],"rational":[159],"this":[161,262,974],"strategy":[162],"comes":[163],"from":[164,200,784,876,895,945],"physiological":[166,263],"constraints":[167],"governing":[168],"absorption":[170,827],"intestinal":[172,234,310,361,393,574,602],"lymphatics":[173],"after":[174,810,848,899,913,942],"oral":[175,424,800,856],"administration.":[176,901],"majority":[178],"orally":[180],"administered":[181,397,407,419],"small":[182],"molecule":[183],"drugs":[184],"(such":[185],"as":[186,203,244,694,696],"FTC)":[187],"are":[188],"fact":[190],"taken":[191],"up":[192,806],"blood":[194,491],"stream":[195],"(as":[196],"opposed":[197],"lymph)":[199],"enterocyte,":[202],"higher":[208,213,483,499,516,628,771],"flow":[209],"rate":[210],"(500":[211],"times":[212],"than":[214,489,502,633,830,919,968],"lymph).":[215],"Instead,":[216],"highly":[217],"compounds":[219],"(Log":[220],"D7.4":[221],">":[222],"5),":[223],"appropriate":[225],"physicochemical":[226],"properties,":[227],"high":[229,548,740],"triglyceride":[230,658,670],"solubility":[231,329,355,671,698],"undergo":[233],"lymphatic":[235,311,362,394,552,575],"transport":[236,553,576],"upon":[237],"being":[238],"co-administered":[239],"lipids.":[241],"occurs":[243],"association":[249,352,629],"chylomicrons.":[255,342],"project":[257,975],"therefore":[258,358],"use":[261],"route":[264],"FTC":[270,285,371,546,861,874,891,911,924,983],"nodes.":[278,935],"Initially,":[279],"HPLC-UV":[281],"analytical":[282],"method":[283],"determination":[286],"rat":[288,617],"was":[290,313,463,523,534,554,596,762,792,803,828,957],"developed,":[291],"achieving":[292],"limit":[294],"quantification":[296],"10":[298],"ng/mL":[299,305,870],"linearity":[301],"over":[302,734],"10-12,000":[304],"range.":[306],"FTC\u2019s":[307],"potential":[308,991],"targeting":[312],"assessed":[314],"silico,":[316],"using":[317,615,993],"previously":[319],"published":[320],"model,":[321,611],"vitro,":[324],"based":[325],"on":[326,370,392,518,715],"compound\u2019s":[328],"olive":[331,411,700],"oil":[332,412,741],"(triglyceride":[333],"solubility)":[334],"ability":[337,589],"associate":[339],"artificial":[341,631],"Both":[343],"silico":[345,550],"vitro":[348,390,564,610,648,971],"screenings":[349],"showed":[350,432,481,622,667,688,719,778,906],"negligible":[351],"negligeable":[354],"oil,":[357],"low":[359,657],"predicted":[360,551,823],"transport.":[363],"Pharmacokinetics":[364],"biodistribution":[366,461,904,981],"studies":[367,777,905],"were":[368,399,579,815,853,916,940,949],"performed":[369],"(dosed":[372],"at":[373,445,465,471,492,508],"20":[374],"mg/kg":[375],"male":[377],"Sprague":[378],"Dawley":[379],"rats)":[380],"assess":[382],"pharmacokinetics":[384,776],"parameters":[385],"confirm":[387],"findings":[391,814],"targeting.":[395],"Orally":[396],"animals":[398],"divided":[400],"two":[402],"groups:":[403],"group":[406,418,478,858],"(1":[413],"mL/kg),":[414],"lipid-free":[417,428,799],"only.":[422],"After":[423],"administration":[425,801,849,915],"group,":[429],"relatively":[434,739],"short":[435],"half-life":[436],"(2.7":[437],"\u00b1":[438,837,863,868,879,884],"0.6":[439],"h),":[440],"tmax":[442,469,835],"observed":[443,468],"either":[444],"0.5":[446,509],"or":[447],"1":[448,493,838],"h.":[449,473,839],"Co-administration":[450],"lipids":[452,530],"led":[453],"broadly":[456],"comparable":[457],"pharmacokinetic":[458],"profile.":[459],"study":[462],"conducted":[464,566],"both":[466,796],"2":[472,495,511,836,943],"Unexpectedly,":[474],"significantly":[482,498,917],"concentrations":[484,909],"h,":[496],"tissue:blood":[500],"ratio":[501],"almost":[503,893],"any":[504],"other":[505,717],"node":[507],"h":[512,809,944],"(range":[513],"1.76-3.15":[514],"folds":[515],"depending":[517],"node).":[520],"behaviour":[522],"reproducible":[524],"also":[525],"without":[526],"co-administration":[528],"suggesting":[531,961],"that":[532,623,779,907,962],"it":[533],"not":[535,793],"driven":[536],"chylomicron":[538,772],"association.":[539,773],"A":[540],"library":[541],"prodrugs":[544,578,625,639,663,704,994],"subsequently":[555],"designed":[556],"synthesised.":[558],"In":[559,660,774,902],"addition":[560],"screening":[565],"parent":[569,635,781],"compound":[570],"assessment":[572],"potential,":[577],"evaluated":[580],"their":[582,588],"stability":[583,649,674,690,1007],"gastro-intestinal":[585],"tract":[586],"cleave":[591,722],"lymph.":[593],"former":[595],"done":[597],"fasted":[600],"simulated":[601],"fluid":[603],"(FaSSIF)":[604],"added":[606,731],"esterase":[607,732],"activity":[608,733],"latter":[613],"model.":[619],"all":[624,926],"had":[626,643],"chylomicrons":[632],"drug.":[636],"Furthermore,":[637,954],"ester":[638,662],"saturated":[641,712],"promoieties":[642,666],"most":[645],"prolonged":[646],"gastrointestinal-":[651],"lymph-mimicked":[654,678],"environments,":[655],"but":[656,672],"solubility.":[659,742],"contrast,":[661],"unsaturated":[665],"highest":[669],"limited":[673,697],"gastrointestinal":[676],"environments.":[679],"amide":[681],"synthesised":[683],"(a":[684],"stearic":[685],"acid":[686],"derivative)":[687],"poor":[689],"gastrointestinal-mimicked":[692],"environment,":[693],"well":[695],"oil.":[701],"carbamate":[703,997],"investigated":[705],"(an":[706],"oleyl":[707,758],"alcohol":[708,759],"derivative":[709,760],"self-immolative":[713],"derivative),":[714],"hand,":[718],"selectively":[721],"remain":[726],"unmodified":[727,832,842,860,923],"FaSSIF":[729],"long":[735,1006],"periods,":[736],"while":[737],"having":[738],"made":[744],"them":[745],"good":[746],"candidates":[747],"take":[749],"further":[750],"vivo":[753,775,903,964],"studies.":[754],"them,":[756],"CA2":[761,786,852,877,914],"selected":[763],"because":[764],"ease":[767],"synthesis":[769],"release":[783,820,1002],"occurred":[788],"rapidly:":[789],"detected":[794],"following":[795],"measurable":[804],"only":[805],"3":[808],"intravenous":[811],"dosing.":[812],"consistent":[816],"rapid":[819],"vitro.":[825],"slower":[829,967],"FTC,":[833,843],"Compared":[840],"AUC":[844],"Cmax":[846],"achieved":[847,912,921],"lower,":[854],"(in":[855],"15149":[862],"2011":[864],"h*ng/mL":[865,881],"5599":[867],"587":[869],"respectively":[871],"vs":[872],"released":[875],"6424":[878],"917":[880],"1594":[883],"293":[885],"ng/mL).":[886],"As":[887],"result,":[889],"bioavailability":[892],"halved":[894],"99%":[896],"61%":[898],"lower":[918],"those":[920],"organs":[930],"analysed,":[931],"including":[932],"Notably,":[936],"when":[937],"tissue:plasma":[938],"ratios":[939],"examined":[941],"administration,":[946],"differences":[948],"longer":[951],"statistically":[952],"significant.":[953],"intact":[955],"present":[958],"lymph,":[960],"conversion":[965],"proceeded":[966],"predictions.":[972],"Overall,":[973],"provided":[976],"new":[977],"insights":[978],"different":[985],"demonstrated":[989],"promoiety":[998],"selective":[1001],"gastointestinal-tract.":[1009]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W7217120482","counts_by_year":[],"updated_date":"2026-10-04T09:36:47.201465","created_date":"2026-10-03T00:00:00"}
